Last Updated : July 26, 2024
Details
| Call for patient/clinician input open | 30-Jun-23 |
|---|---|
| Call for patient/clinician input closed | 25-Aug-23 |
| Clarification: - No patient input submission received | |
| Submission received | 14-Aug-23 |
| Submission accepted | 30-Aug-23 |
| Review initiated | 31-Aug-23 |
| Clarification: - Submission was not accepted for review on 28 Aug 2023 | |
| Draft Canada's Drug Agency review report(s) provided to sponsor for comment | 24-Nov-23 |
| Deadline for sponsors comments | 05-Dec-23 |
| Canada's Drug Agency review report(s) and responses to comments provided to sponsor | 12-Jan-24 |
| Expert committee meeting (initial) | 24-Jan-24 |
| Draft recommendation issued to sponsor | 06-Feb-24 |
| Draft recommendation posted for stakeholder feedback | 15-Feb-24 |
| End of feedback period | 01-Mar-24 |
| Final recommendation issued to sponsor and drug plans | 18-Mar-24 |
| Final recommendation posted | 04-Apr-24 |
| Deadline for sponsor to submit redaction requests on draft Canada's Drug Agency review report(s) | 02-Apr-24 |
| Canada's Drug Agency review report(s) posted | 25-Jul-24 |